Piet Wigerinck

Company: Fibrocor Therapeutics

Job title: Chief Scientific Advisor


Blocking the Matrix Stiffness Signal: From Patient to Clinical Candidate 2:00 pm

• Interrogation of progressive patients biopsies, a unique approach to fibrosis • Exploring the matrix stiffness and its untapped promise as an alternative approach in IPF • Leveraging tissue biomarkers to guide dose selection Read more

day: Day Two Track A PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.